Page last updated: 2024-10-22

amitriptyline and Factitious Disorders

amitriptyline has been researched along with Factitious Disorders in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Factitious Disorders: Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devlin, I1
O'Rahilly, S1
Turner, TH1
Wass, JA1

Other Studies

2 other studies available for amitriptyline and Factitious Disorders

ArticleYear
Antidepressant melodies.
    Australian family physician, 1986, Volume: 15, Issue:2

    Topics: Aged; Amitriptyline; Depression; Factitious Disorders; Female; Hallucinations; Humans; Vitamin B 12

1986
Factitious epilepsy due to amitryptyline abuse.
    Irish medical journal, 1985, Volume: 78, Issue:6

    Topics: Adult; Amitriptyline; Epilepsy, Tonic-Clonic; Factitious Disorders; Female; Humans; Substance-Relate

1985